Newsfeeds - Spark Newswire

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

Today, 7:32 AM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ABBV

2 minute read

10 Stocks That Have Moved Over 20% Since The Indices Lost Over 12%!

By Zaheer Anwari

Today, 7:32 AM

The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.

ABBV

1 minute read

Amphastar’s Generic Ganirelix Acetate Injection Scores FDA Approval

By Vandana Singh

Today, 7:32 AM

The FDA has approved Amphastar Pharmaceuticals Inc’s (NASDAQ:AMPH) Abbreviated New Drug Application for Ganirelix Acetate Injection, 250mg/0.5mL in a prefilled syringe. …

AMPH

1 minute read

Amphastar Reports Received FDA Approval For Ganirelix Acetate Injection

By Benzinga Newsdesk

Today, 7:32 AM

-Dow Jones

AMPH

6 minute read

Stocks That Hit 52-Week Highs On Thursday

By Benzinga Insights

Today, 7:32 AM

On Thursday, 75 stocks made new 52-week highs.

ABBV

1 minute read

Wells Fargo Maintains Equal-Weight on Amphastar Pharmaceuticals, Raises Price Target to $32

By Benzinga Newsdesk

Today, 7:32 AM

Wells Fargo analyst Jacob Hughes maintains Amphastar Pharmaceuticals (NASDAQ:AMPH) with a Equal-Weight and raises the price target from $23 to $32.

AMPH

1 minute read

Piper Sandler Maintains Overweight on Amphastar Pharmaceuticals, Raises Price Target to $35

By Benzinga Newsdesk

Today, 7:32 AM

Piper Sandler analyst David Amsellem maintains Amphastar Pharmaceuticals (NASDAQ:AMPH) with a Overweight and raises the price target from $28 to $35.

AMPH

1 minute read

Earnings

Amphastar Pharmaceuticals: Q4 Earnings Insights

By Benzinga Insights

Today, 7:32 AM

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

AMPH

1 minute read

Earnings

Earnings Preview For Amphastar Pharmaceuticals

By Benzinga Insights

Today, 7:32 AM

Amphastar Pharmaceuticals (NASDAQ:AMPH) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts estimate that Amphastar Pharmaceuticals will report an earnings per share (EPS) of $0.37.

AMPH

3 minute read

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg

By Shanthi Rexaline

Today, 7:32 AM

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in four out of five sessions of the week.

ACHV